Challenges and opportunities for development of an AIDS vaccine
Open Access
- 1 April 2001
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 410 (6831), 1002-1007
- https://doi.org/10.1038/35073500
Abstract
Among the devastating consequences of AIDS has been its epidemic spread in the developing world. The disease has caused unprecedented suffering, debilitation, loss of life and disruption of family, social and economic stability. Because of the considerable expense and logistical difficulty in providing antiviral drugs to populations infected with the human immunodeficiency virus throughout the world, the biomedical community is looking towards vaccines to help solve this compelling problem.Keywords
This publication has 74 references indexed in Scilit:
- A Controversial Shot in the ArmScience News, 1999
- Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirusGene Therapy, 1999
- Fusion-Competent Vaccines: Broad Neutralization of Primary Isolates of HIVScience, 1999
- DNA VACCINESAnnual Review of Immunology, 1997
- Adjuvants—a classification and review of their modes of actionVaccine, 1997
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- Genomic Structure of an Attenuated Quasi Species of HIV-1 from a Blood Transfusion Donor and RecipientsScience, 1995
- Human Studies in the Development of Human Immunodeficiency Virus VaccinesThe Journal of Infectious Diseases, 1995
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993
- Importance of the nef gene for maintenance of high virus loads and for development of AIDSCell, 1991